CM-1758 is a histone deacetylase (HDAC) inhibitor. CM-1758 inhibits tumor growth in vivo. CM-1758 induces acetylation of non-histone proteins in acute myeloid leukemia cells.
References:
[1]. José-Enériz ES, et al. Novel epigenetic based differentiation therapy for Acute Myeloid Leukemia. Europe PMC. 2023.
















